GlassScriptPhysician profile
Geet Paul
NPI 1265725436
$18,327.55
in general payments reported to CMS, 2019-2025
26 companies · $4,232 in 2025
The $4,232 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,414 · 2020: $666 · 2021: $1,434 · 2022: $3,205 · 2023: $2,669 · 2024: $4,708 · 2025: $4,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,824 · Travel and Lodging: $2,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,823.95 |
| Travel and Lodging | $2,785.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,925.96 | 2019-2025 | Proclaim, Eterna, Axium |
| Medtronic, INC. | $4,901.89 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $3,839.86 | 2019-2025 | Superion Indirect Decompression System, Intracept, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $601.90 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $599.44 | 2019-2020 | |
| Spr Therapeutics, INC | $593.85 | 2019-2025 | Sprint Pns System |
| Nevro Corp. | $475.96 | 2019-2024 | Senza |
| Painteq LLC | $437.36 | 2024 | Painteq |
| Abbvie INC. | $367.58 | 2023-2025 | |
| Avanir Pharmaceuticals, INC. | $236.55 | 2022 | |
| Vertos Medical, INC. | $203.52 | 2023-2024 | Mild Device Kit |
| Bioness INC | $200.17 | 2020 | |
| 4web, INC. | $149.36 | 2021 | |
| Biotronik Nro, INC. | $140.19 | 2025 | Prospera |
| Si-Bone, INC. | $119.78 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $114.71 | 2025 | Stimrouter Implantable Kit |
| Stability Biologics, LLC | $109.74 | 2022 | |
| Globus Medical, INC. | $58.39 | 2025 | Senza, Omnia |
| Stryker Corporation | $52.98 | 2025 | Spinejack, Optablate |
| Allergan, INC. | $52.40 | 2019-2021 | |
| Stratus Medical, LLC | $43.60 | 2023 | Nimbus |
| Argenx US, INC. | $25.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.66 | 2022 | |
| Ucb, INC. | $19.59 | 2021 | |
| Lenoss Medical INC | $16.91 | 2025 | Osteopearl |
| Biohaven Pharmaceutical Holding Company LTD. | $15.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geet Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.